1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting ceruloplasmin. Nat Commun. 7:119962016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang Y, Lin C, Liao G, Liu S, Ding J,
Tang F, Wang Z, Liang X, Li B, Wei Y, et al: MicroRNA-506
suppresses tumor proliferation and metastasis in colon cancer by
directly targeting the oncogene EZH2. Oncotarget. 6:32586–32601.
2015.PubMed/NCBI
|
5
|
Zeng M, Zhu L, Li L and Kang C: miR-378
suppresses the proliferation, migration and invasion of colon
cancer cells by inhibiting SDAD1. Cell Mol Biol Lett. 22:122017.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Frouws MA, Reimers MS, Swets M,
Bastiaannet E, Prinse B, van Eijk R, Lemmens VE, van Herk-Sukel MP,
van Wezel T, Kuppen PJ, et al: The Influence of BRAF and KRAS
mutation status on the association between aspirin use and survival
after colon cancer diagnosis. PLoS One. 12:e01707752017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lam MT, Li W, Rosenfeld MG and Glass CK:
Enhancer RNAs and regulated transcriptional programs. Trends
Biochem Sci. 39:170–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Boon RA, Jaé N, Holdt L and Dimmeler S:
Long noncoding RNAs: From clinical genetics to therapeutic targets?
J Am Coll Cardiol. 67:1214–1226. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang J, Wang P, Wan L, Xu S and Pang D:
The emergence of noncoding RNAs as Heracles in autophagy.
Autophagy. 13:1004–1024. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Dangwal S, Schimmel K, Foinquinos A, Xiao
K and Thum T: Noncoding RNAs in heart failure. Handb Exp Pharmacol.
243:423–445. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Bär C, Chatterjee S and Thum T: Long
noncoding RNAs in cardiovascular pathology, diagnosis, and therapy.
Circulation. 134:1484–1499. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Tong X, Gu PC, Xu SZ and Lin XJ: Long
non-coding RNA-DANCR in human circulating monocytes: A potential
biomarker associated with postmenopausal osteoporosis. Biosci
Biotechnol Biochem. 79:732–737. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sha S, Yuan D, Liu Y, Han B and Zhong N:
Targeting long non-coding RNA DANCR inhibits triple negative breast
cancer progression. Biol Open. 6:1310–1316. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mao Z, Li H, Du B, Cui K, Xing Y, Zhao X
and Zai S: LncRNA DANCR promotes migration and invasion through
suppression of lncRNA-LET in gastric cancer cells. Biosci Rep.
37:pii: BSR20171070. 2017. View Article : Google Scholar
|
17
|
Jia J, Li F, Tang XS, Xu S, Gao Y, Shi Q,
Guo W, Wang X, He D and Guo P: Long noncoding RNA DANCR promotes
invasion of prostate cancer through epigenetically silencing
expression of TIMP2/3. Oncotarget. 7:37868–37881. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dumars C, Ngyuen JM, Gaultier A, Lanel R,
Corradini N, Gouin F, Heymann D and Heymann MF: Dysregulation of
macrophage polarization is associated with the metastatic process
in osteosarcoma. Oncotarget. 7:78343–78354. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Liu Y, Zhang M, Liang L, Li J and Chen YX:
Over-expression of lncRNA DANCR is associated with advanced tumor
progression and poor prognosis in patients with colorectal cancer.
Int J Clin Exp Pathol. 8:11480–11484. 2015.PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu
J, Miao N, Shen J and Peng T: lncRNA DANCR promotes tumor
progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55.
2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang L, Yang C, Chen S, Wang G, Shi B,
Tao X, Zhou L and Zhao J: Long noncoding RNA DANCR Is a positive
regulator of proliferation and chondrogenic differentiation in
human Synovium-derived stem cells. DNA Cell Biol. 36:136–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Yuan SX, Wang J, Yang F, Tao QF, Zhang J,
Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, et al: Long noncoding RNA
DANCR increases stemness features of hepatocellular carcinoma by
derepression of CTNNB1. Hepatology. 63:499–511. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jin L, Fu H, Quan J, Pan X, He T, Hu J, Li
Y, Li H, Yang Y, Ye J, et al: Overexpression of long non-coding RNA
differentiation antagonizing non-protein coding RNA inhibits the
proliferation, migration and invasion and promotes apoptosis of
renal cell carcinoma. Mol Med Rep. 16:4463–4468. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhang L, Sun X, Chen S, Yang C, Shi B,
Zhou L and Zhao J: Long noncoding RNA DANCR regulates miR-1305-Smad
4 axis to promote chondrogenic differentiation of human
synovium-derived mesenchymal stem cells. Biosci Rep. 37:pii:
BSR20170347. 2017. View Article : Google Scholar
|
26
|
Chen L, Song Z, Huang S, Wang R, Qin W,
Guo J and Lin Z: lncRNA DANCR suppresses odontoblast-like
differentiation of human dental pulp cells by inhibiting
wnt/β-catenin pathway. Cell Tissue Res. 364:309–318. 2016.
View Article : Google Scholar : PubMed/NCBI
|